Ukraine’s frontline winemakers defy war to keep hope—and vines—alive

The day’s news unfolds like a map of quiet defiance. In Ukraine, winemakers prune vines within earshot of Russian drones, their persistence a rebuke to war’s chaos. In Washington, the sudden death of Senator Lindsey Graham leaves a void in Republican strategy, while in Britain, the arrest of a man in connection with Ann Widdecombe’s death adds a grim coda to the former MP’s polarising legacy. Elsewhere, fraudsters weaponise fake news stories to lure victims into investment scams, and endometriosis campaigners demand faster diagnoses—reminders that resilience takes many forms, from the battlefield to the clinic.

The vines that refuse to surrender

In the sun-drenched steppe of southern Ukraine, Mykhailo Molchanov moves through his organic vineyard with the methodical care of a man who has learned to ignore the buzz of drones overhead. His winery, Steppe Wines, is a testament to stubborn hope: planted in biodiverse grassland near the frontline, its vines thrive despite the ever-present threat of unexploded ordnance. “To make wine is to believe in the future,” Molchanov told The Guardian this week, his words carrying the weight of a region where every harvest feels like a small victory.

The war has upended Ukraine’s wine industry, once a source of national pride and economic stability. Vineyards in occupied Crimea and the Donbas have been seized or destroyed, while those in safer regions face labour shortages and export blockades. Yet winemakers like Molchanov persist, their work a quiet act of resistance. “We’re not just growing grapes,” said one producer. “We’re proving this land is still ours.” The industry’s survival is more than symbolic—it provides jobs, sustains local economies, and offers a rare sense of normalcy amid the ruins. As one sommelier put it, “Every bottle sold is a message: Ukraine is still here.”

A political giant’s sudden exit

The death of Lindsey Graham, the Republican senator and former Trump critic turned loyal ally, has sent shockwaves through Washington. Graham, 71, had been a fixture in U.S. politics since 2003, his sharp tongue and strategic mind shaping debates from foreign policy to judicial appointments. His passing leaves a void in the Senate, where his ability to bridge divides—however imperfectly—had made him a key player in bipartisan negotiations. “He was a dealmaker in an era of deadlock,” said a colleague, though critics noted his late-career pivot toward Trumpism had alienated former allies.

Graham’s death comes at a fraught moment for U.S.-UK relations, already strained by trade disputes and differing approaches to Ukraine. His hawkish stance on Russia had aligned closely with London’s, and his absence may embolden isolationist voices within the GOP. For Britain, the timing is particularly delicate: with the U.S. election looming and Ukraine’s counteroffensive stalling, Graham’s influence on military aid packages had been pivotal. His legacy, like his career, is one of contradictions—both a unifier and a divider, a man who could charm and infuriate in equal measure.

Shadows over a political legacy

The arrest of a 28-year-old man on suspicion of murder in the death of Ann Widdecombe has cast a dark pall over the former MP’s already contentious legacy. Widdecombe, who died last week, had been a lightning rod in British politics, her unapologetic conservatism and Brexit fervour earning her both devotion and derision. The investigation, which police describe as “complex,” has raised uncomfortable questions about the risks faced by public figures—and the toxic undercurrents of political discourse.

Widdecombe’s career spanned four decades, from her early days as a Tory MP to her later role as a media firebrand. She was a vocal opponent of same-sex marriage, a defender of fox hunting, and a staunch advocate for Brexit, even as her party fractured over the issue. Her death had already reignited debates about the direction of the Conservative Party, with some framing her as a martyr for traditional values and others as a relic of a bygone era. The arrest adds a grim twist to that narrative, forcing a reckoning with the darker side of political polarisation.

The scammers’ new playbook

Fraudsters are exploiting the trust in established media brands, creating convincing fake news stories to lure victims into investment scams. One recent example, shared widely on social media, purports to be a Guardian article claiming billionaire Jim Ratcliffe stormed out of a BBC interview after being confronted about his “secret” investment platform. The story is entirely fabricated—complete with a fake iPlayer link and testimonials from non-existent users—but its polished presentation has fooled thousands.

The tactic preys on the credibility of legacy media, using cloned websites and AI-generated content to create a veneer of legitimacy. “It’s a very good clone,” said one cybersecurity expert, noting that the scammers even replicate the layout and tone of real publications. The rise of such schemes reflects a broader erosion of trust in information, where even savvy readers can be deceived by sophisticated forgeries. Regulators are scrambling to respond, but the cat-and-mouse game favours the fraudsters—for now.

A diagnosis delayed

Endometriosis campaigners are warning that women in the UK still face agonising waits for diagnosis, despite the introduction of two new non-invasive tests. The condition, which affects one in ten women, can take up to a decade to diagnose under the current system, leaving patients in chronic pain and at risk of infertility. “We’re crying out for change,” said one advocate, pointing to the emotional and financial toll of delayed treatment.

The new tests, which analyse biomarkers in blood or urine, offer a glimmer of hope—but only if GPs adopt them widely. Critics argue that the NHS’s slow rollout reflects a broader neglect of women’s health, with conditions like endometriosis historically dismissed as “just bad periods.” The push for faster diagnoses comes as the government faces mounting pressure to overhaul its approach to women’s healthcare, from menstrual health education to fertility services. For now, the wait continues.

The day’s stories converge on a single theme: resilience in the face of disruption. Whether in the vineyards of Ukraine, the halls of Washington, or the clinics of Britain, the act of carrying on—of tending vines, shaping policy, or demanding better care—is itself a form of defiance. The question is not whether these efforts will succeed, but what they reveal about the human instinct to build, even in the ruins.